3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Waldenstrom Macroglobulinemia
1
Thrombocythemia, Essential
1
Sezary Syndrome
1
Recurrence
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polycythemia Vera
1
Pdgfra-Associated Chronic Eosinophilic Leukemia
1
Myeloproliferative Disorders
1
Mycosis Fungoides
1
Multiple Myeloma
1
Mastocytosis
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Follicular
1
Lymphoma, Extranodal NK-T-Cell
1
Lymphoma, B-Cell, Marginal Zone
1
Leukemia, Neutrophilic, Chronic
1
Leukemia, Myelomonocytic, Juvenile
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Acute
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia, Large Granular Lymphocytic
1
Leukemia, Hairy Cell
1
Hodgkin Disease
1
Hepatoblastoma
1
Dupuytren Contracture
1
Congenital Abnormalities
1
Anemia, Refractory
1
Anemia, Aplastic
1
Interventions
fludarabine
4
fludarabine phosphate
3
asciminib
3
venetoclax
2
gilteritinib
2
Whole-Body Irradiation
2
Tacrolimus
2
Idarubicin
2
Cytarabine
2
Cyclophosphamide
2
Busulfan
2
Bone Marrow Transplantation
2
ponatinib
1
nilotinib
1
enasidenib
1
blinatumomab
1
aldesleukin
1
Thiotepa
1
Peripheral Blood Stem Cell Transplantation
1
Patient Reported Outcome Measures
1
N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide
1
Mycophenolic Acid
1
Methotrexate
1
Mesna
1
Melphalan
1
Interleukin-2
1
Imatinib Mesylate
1
Hyperbaric Oxygenation
1
Granulocyte Colony-Stimulating Factor
1
Filgrastim
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Myeloid
×
Transplantation
×
90 days
×
Clear all
No trials found.